Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized controlled trials

    Research output: Contribution to journalReview articlepeer-review

    317 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

    Medicine & Life Sciences